Amela Jusić

492 citations
16 papers · 306 indexed · h-index 9
Topics
RNA modifications and cancer (7 papers)Cancer-related molecular mechanisms research (7 papers)MicroRNA in disease regulation (7 papers)
Journals
SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesHypertension

In The Last Decade

Amela Jusić

15 papers receiving 302 citations

Peers

Amela Jusić
Comparison fields: 5 of 64
  • Molecular Biology 181
  • Cancer Research 146
  • Cardiology and Cardiovascular Medicine 58
  • Physiology 30
  • Hematology 22
Replace Hui Zhai with:
Hui Zhai China
Peter Bobbert Germany
Anna Sobol Poland
Guo-Hong Yang China
Jinfa Jiang China
Edward Duran United States
Huanji Zhang China
Ananth M. Prasan Australia
Maria Zolindaki Greece
Amela Jusić relative to Hui Zhai China Hui Zhai's profile →
Citations per field
00.5×3.7×
Hui Zhai · 1×
Citations per year

Countries citing papers authored by Amela Jusić

Since Specialization
Citations

This map shows the geographic impact of Amela Jusić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amela Jusić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amela Jusić more than expected).

Fields of papers citing papers by Amela Jusić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amela Jusić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amela Jusić. The network helps show where Amela Jusić may publish in the future.

Co-authorship network of co-authors of Amela Jusić

This figure shows the co-authorship network connecting the top 25 collaborators of Amela Jusić. A scholar is included among the top collaborators of Amela Jusić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amela Jusić. Amela Jusić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 3
3 5
4 4
5 12
6 7
7 51
8 13
9 21
10 71
11 16
12 7
13 68
14 16
15 0
16 11

About Amela Jusić

Amela Jusić is a scholar working on Cancer Research, Internal Medicine and Hematology, having authored 16 papers that have together received 306 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (146 citations), Internal Medicine (13 citations) and Aging (6 citations). Amela Jusić has collaborated with scholars based in Bosnia and Herzegovina, Luxembourg and Netherlands. Frequent co-authors include Yvan Devaux, Emma Robinson, Konstantinos Stellos, F Pinet, Rosienne Farrugia, Simon Tual‐Chalot, Soner Doğan, Stephanie Bezzina Wettinger, Carlo Gaetano and Fabio Martelli. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026